“…As these sensors are proteins which can be genetically encoded, they allow cell type specific expression using specific promoters as well as subcellular targeting using appropriate targeting sequences. Combined with different stateof-the art microscopy technologies, the dynamics of metabolites can be followed in cultured cells, in tissue preparations like brain slices or the isolated optic nerve, but also in vivo in living and even awake animals (Bittner et al, 2011;Ruminot et al, 2011;Mächler et al, 2016;Díaz-García et al, 2017, 2019Trevisiol et al, 2017;Köhler et al, 2018;Baeza-Lehnert et al, 2019;Gerkau et al, 2019;Lerchundi et al, 2019;Arce-Molina et al, 2020;Zuend et al, 2020). However, while these nanosensors readily allow for monitoring relative changes of the metabolite concentration, deduction of absolute concentrations and absolute concentration changes (i.e., in mol/l) during treatments has remained challenging as calibration of the signal of the nanosensors to the actual concentration of the metabolite is hampered by both, theoretical and practical problems (Barros et al, 2018a).…”